Toward the beginning of the new year, we like to take a look at some of the biggest trends that will affect the pharmaceutical industry in the coming months. This year, trending developments range from AI...
BioCare, Inc., specializing in delivering specialty and therapeutic biological products since 1982, has named two healthcare industry veterans to their leadership team. Healthcare sales executive Mike Collins was named Vice President of Sales for BioCareSD, the company's specialty...
BioCareSD, a specialty distributor of life-saving therapies, today announced that ALTUVIIIO [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl], previously referred to as efanesoctocog alfa, is now available through their network. It is indicated for routine prophylaxis and...
In the healthcare supply chain world, the year 2020 created a notable split. Even those not directly involved in the healthcare industry, that would otherwise have no vested interest in healthcare-specific supply chain knowledge, felt the...
For the past two and a half years, organizations have had to learn to operate across remote and hybrid environments at an unprecedented rate. Initially, the issues that stemmed from immediate and widespread remote work were plentiful:...
The 2020 COVID-19 pandemic has made a permanent mark on the healthcare industry. Many changes have taken place, new regulations and requirements are set for future implementation, and patients are now expecting a new standard of...
BioCareSD, a specialty distributor of life-saving therapies, today announced the addition of VIBATIV® and ULTOMIRIS® to its already extensive portfolio of life-saving therapies. With an ongoing commitment to broadening its product portfolio, BioCareSD is dedicated to...
The United States Food and Drug Administration (FDA) estimates that more than 30 million people living in the U.S. are affected by over 7,000 rare diseases. Many of these rare diseases do not have a known...
Supply chain professionals must consider immediate impacts and contemplate possible implications for materials. As always, in developing internal supply chains, evaluating vendors and supplies, contingency planning, and communication will be critical. This major challenge highlights the need for...
Cold supply chains are necessary to ensure the efficacy of certain medications, vaccines and other biopharmaceutical products, but the addition of extreme temperatures presents new obstacles that can make the process even more difficult to manage...
